These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. Amato MP, Portaccio E, Goretti B, Zipoli V, Battaglini M, Bartolozzi ML, Stromillo ML, Guidi L, Siracusa G, Sorbi S, Federico A, De Stefano N. Arch Neurol; 2007 Aug; 64(8):1157-61. PubMed ID: 17698706 [Abstract] [Full Text] [Related]
5. Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings. Piras MR, Magnano I, Canu ED, Paulus KS, Satta WM, Soddu A, Conti M, Achene A, Solinas G, Aiello I. J Neurol Neurosurg Psychiatry; 2003 Jul; 74(7):878-85. PubMed ID: 12810771 [Abstract] [Full Text] [Related]
6. Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis. Pinter D, Khalil M, Pichler A, Langkammer C, Ropele S, Marschik PB, Fuchs S, Fazekas F, Enzinger C. Neuroimage Clin; 2015 Jul; 7():715-20. PubMed ID: 25844323 [Abstract] [Full Text] [Related]
7. Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach. Uher T, Vaneckova M, Sormani MP, Krasensky J, Sobisek L, Dusankova JB, Seidl Z, Havrdova E, Kalincik T, Benedict RH, Horakova D. Eur J Neurol; 2017 Feb; 24(2):292-301. PubMed ID: 27873386 [Abstract] [Full Text] [Related]
8. Spatial distribution of white matter degenerative lesions and cognitive dysfunction in relapsing-remitting multiple sclerosis patients. Nowaczyk N, Kalinowska-Łyszczarz A, Paprzycki W, Michalak S, Kaźmierski R, Pawlak MA. Neurol Neurochir Pol; 2019 Feb; 53(1):18-25. PubMed ID: 30742302 [Abstract] [Full Text] [Related]
16. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Benedict RH, Weinstock-Guttman B, Fishman I, Sharma J, Tjoa CW, Bakshi R. Arch Neurol; 2004 Feb; 61(2):226-30. PubMed ID: 14967771 [Abstract] [Full Text] [Related]
17. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis. Nocentini U, Bozzali M, Spanò B, Cercignani M, Serra L, Basile B, Mannu R, Caltagirone C, De Luca J. Brain Imaging Behav; 2014 Sep; 8(3):378-86. PubMed ID: 22584774 [Abstract] [Full Text] [Related]
18. A longitudinal study of cognition in primary progressive multiple sclerosis. Camp SJ, Stevenson VL, Thompson AJ, Ingle GT, Miller DH, Borras C, Brochet B, Dousset V, Falautano M, Filippi M, Kalkers NF, Montalban X, Polman CH, Langdon DW. Brain; 2005 Dec; 128(Pt 12):2891-8. PubMed ID: 16049040 [Abstract] [Full Text] [Related]
19. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, Giorgio A, Bartolozzi ML, Guidi L, Sorbi S, Federico A, Amato MP, De Stefano N. Neurology; 2009 Aug 18; 73(7):498-503. PubMed ID: 19641173 [Abstract] [Full Text] [Related]
20. Cognitive event-related potentials in multiple sclerosis: Correlation with MRI and neuropsychological findings. Kimiskidis VK, Papaliagkas V, Sotirakoglou K, Kouvatsou ZK, Kapina VK, Papadaki E, Tsimourtou V, Masoura E, Kazis DA, Papayiannopoulos S, Geroukis T, Bostanjopoulou S. Mult Scler Relat Disord; 2016 Nov 18; 10():192-197. PubMed ID: 27919489 [Abstract] [Full Text] [Related] Page: [Next] [New Search]